{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:36:21Z","timestamp":1787668581369,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"DOI":"10.7759\/cureus.95986","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:06:21Z","timestamp":1762164381000},"source":"Crossref","is-referenced-by-count":2,"title":["Anesthesiologists\u2019 Perspectives on GLP-1 Receptor Agonists in Elective Surgeries: A Qualitative Survey Analysis of National Data"],"prefix":"10.7759","author":[{"given":"Benjamin","family":"Boudreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck MA","year":"2021","unstructured":"Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Mol Metab. 2021, 46:101102. 10.1016\/j.molmet.2020.101102","journal-title":"Mol Metab"},{"key":"ref2","unstructured":"U.S. Food and Drug Administration. FDA approves new drug treatment for chronic weight management, first since 2014. (2021). Accessed. January 31, 2025: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-medication-chronic-weight-management."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.10333","article-title":"Roughly 12% of US adults have used a GLP-1 drug, even if unaffordable","volume":"332","author":"Harris E","year":"2024","unstructured":"Harris E. Roughly 12% of US adults have used a GLP-1 drug, even if unaffordable. JAMA. 2024, 332:8. 10.1001\/jama.2024.10333","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020199","article-title":"Glucagon-like peptide-1 receptor agonists associated gastrointestinal adverse events: a cross-sectional analysis of the national institutes of health all of US cohort","volume":"17","author":"Aldhaleei WA","year":"2024","unstructured":"Aldhaleei WA, Abegaz TM, Bhagavathula AS. Glucagon-like peptide-1 receptor agonists associated gastrointestinal adverse events: a cross-sectional analysis of the national institutes of health all of US cohort. Pharmaceuticals (Basel). 2024, 17:10.3390\/ph17020199","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16099","article-title":"Aspiration risk with glucagon-like peptide 1 (GLP-1) agonists","volume":"78","author":"Marroquin-Harris M","year":"2023","unstructured":"Marroquin-Harris M, Olesnicky B. Aspiration risk with glucagon-like peptide 1 (GLP-1) agonists. Anaesthesia. 2023, 78:1524. 10.1111\/anae.16099","journal-title":"Anaesthesia"},{"key":"ref6","unstructured":"American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. (2023). Accessed. 3 November 2023: https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-...."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216336","article-title":"A scoping review of GLP-1 receptor agonists: are they associated with increased gastric contents, regurgitation, and aspiration events?","volume":"13","author":"Chang MG","year":"2024","unstructured":"Chang MG, Ripoll JG, Lopez E, Krishnan K, Bittner EA. A scoping review of GLP-1 receptor agonists: are they associated with increased gastric contents, regurgitation, and aspiration events?. J Clin Med. 2024, 13:10.3390\/jcm13216336","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16306","article-title":"Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice","volume":"79","author":"Milder DA","year":"2024","unstructured":"Milder DA, Milder TY, Liang SS, Kam PC. Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice. Anaesthesia. 2024, 79:735-47. 10.1111\/anae.16306","journal-title":"Anaesthesia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by glucagon-like peptide-1 agonists: a systematic review and meta-analysis with insights for periprocedural management","volume":"119","author":"Hiramoto B","year":"2024","unstructured":"Hiramoto B, McCarty TR, Lodhia NA, et al.. Quantified metrics of gastric emptying delay by glucagon-like peptide-1 agonists: a systematic review and meta-analysis with insights for periprocedural management. Am J Gastroenterol. 2024, 119:1126-40. 10.14309\/ajg.0000000000002820","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06737-1","article-title":"A consensus-based checklist for reporting of survey studies (CROSS)","volume":"36","author":"Sharma A","year":"2021","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T, et al.. A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021, 36:3179-87. 10.1007\/s11606-021-06737-1","journal-title":"J Gen Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.02.005","article-title":"Reporting guidelines for allergy and immunology survey research","volume":"130","author":"Moore-Clingenpeel M","year":"2023","unstructured":"Moore-Clingenpeel M, Greenhawt M, Shaker M. Reporting guidelines for allergy and immunology survey research. Ann Allergy Asthma Immunol. 2023, 130:674-680.e1. 10.1016\/j.anai.2023.02.005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X0603400219","article-title":"An introductory guide to survey research in anaesthesia","volume":"34","author":"Jones D","year":"2006","unstructured":"Jones D, Story D, Clavisi O, Jones R, Peyton P. An introductory guide to survey research in anaesthesia. Anaesth Intensive Care. 2006, 34:245-53. 10.1177\/0310057X0603400219","journal-title":"Anaesth Intensive Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czab048","article-title":"The devil is in the detail: reflections on the value and application of cognitive interviewing to strengthen quantitative surveys in global health","volume":"36","author":"Scott K","year":"2021","unstructured":"Scott K, Ummer O, LeFevre AE. The devil is in the detail: reflections on the value and application of cognitive interviewing to strengthen quantitative surveys in global health. Health Policy Plan. 2021, 36:982-95. 10.1093\/heapol\/czab048","journal-title":"Health Policy Plan"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5993\/AJHB.23.4.9","article-title":"Establishing content validity: using qualitative and quantitative steps","volume":"23","author":"McKenzie J","year":"1999","unstructured":"McKenzie J, Wood M, Kotecki J, Clark J. Establishing content validity: using qualitative and quantitative steps. Am J Health Behav. 1999, 23:311-8. 10.5993\/AJHB.23.4.9","journal-title":"Am J Health Behav"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0b013e31826a06b2","article-title":"AM last page. Avoiding four visual-design pitfalls in survey development","volume":"87","author":"Artino AR Jr","year":"2012","unstructured":"Artino AR Jr, Gehlbach H. AM last page. Avoiding four visual-design pitfalls in survey development. Acad Med. 2012, 87:1452. 10.1097\/ACM.0b013e31826a06b2","journal-title":"Acad Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0b013e31822f77cc","article-title":"AM last page: avoiding five common pitfalls of survey design","volume":"86","author":"Artino AR Jr","year":"2011","unstructured":"Artino AR Jr, Gehlbach H, Durning SJ. AM last page: avoiding five common pitfalls of survey design. Acad Med. 2011, 86:1327. 10.1097\/ACM.0b013e31822f77cc","journal-title":"Acad Med"},{"key":"ref17","unstructured":"Citing Qualtrics in academic research. (2018). Accessed. March 27, 2025: https:\/\/www.qualtrics.com\/blog\/citing-qualtrics."},{"key":"ref18","unstructured":"Monthly product release notes - June 6, 2024 to July 3, 2024 | XM Community. (2024). Accessed. March 27, 2025: https:\/\/community.qualtrics.com\/product-release-notes-96\/monthly-product-release-notes-june-6-2024-to-july-3-2024-28533."},{"key":"ref19","unstructured":"Most patients can continue diabetes, weight loss GLP-1 drugs before surgery, those at highest risk for gi problems should follow liquid diet before procedure. (2024). Accessed. January 31, 2025: https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2024\/10\/new-multi-society-glp-1-guidance."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2024.08.033","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"20","author":"Kindel TL","year":"2024","unstructured":"Kindel TL, Wang AY, Wadhwa A, et al.. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Obes Relat Dis. 2024, 20:1183-6. 10.1016\/j.soard.2024.08.033","journal-title":"Surg Obes Relat Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000005231","article-title":"Preprocedure care of patients on glucagon-like peptide-1 receptor agonists: a multisociety clinical practice guidance","volume":"141","author":"Joshi GP","year":"2024","unstructured":"Joshi GP, LaMasters T, Kindel TL. Preprocedure care of patients on glucagon-like peptide-1 receptor agonists: a multisociety clinical practice guidance. Anesthesiology. 2024, 141:1208-9. 10.1097\/ALN.0000000000005231","journal-title":"Anesthesiology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.14707\/ajbr.250186","article-title":"Snowball sampling: a review and guidelines for survey research","volume":"15","author":"Ting H","year":"2025","unstructured":"Ting H, Memon MA, Thurasamy R, Cheah JH. Snowball sampling: a review and guidelines for survey research. Asian J Bus Res. 2025, 15:1-15. 10.14707\/ajbr.250186","journal-title":"Asian J Bus Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/339937-anesthesiologists-perspectives-on-glp-1-receptor-agonists-in-elective-surgeries-a-qualitative-survey-analysis-of-national-data","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:06:22Z","timestamp":1762164382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/339937-anesthesiologists-perspectives-on-glp-1-receptor-agonists-in-elective-surgeries-a-qualitative-survey-analysis-of-national-data"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.95986","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}